AnythingResearch - Industry Analysis and Market Research Reports
Better Data, Better Decisions

2018 Market Analysis & Industry Outlook: Biological Product Manufacturing

Overview: the U.S. Biological Product Manufacturing Industry

This section provides answers to key questions about the industry:

  1. What is the total market size (industry revenue)?
  2. What is the industry outlook?
  3. Market Analysis: Is the market growing or declining, and how quickly?
  4. Are long-term forecasts positive or negative?
  5. What is the average company size in the industry?
  6. How many companies are in the industry?

Market Size & Industry Statistics

The total U.S. industry market size for Biological Product Manufacturing: Industry statistics cover all companies in the United States, both public and private, ranging in size from small businesses to market leaders. In addition to revenue, the industry market analysis shows information on employees, companies, and average firm size.

Investors, banks, and business executives use growth rates and industry trends to understand the market outlook and opportunity.

market size 2018
Charts and graphs can be copied to Microsoft Word and Powerpoint presentations.

Statistics 2012        2013        2014        2015        2016        2017
Market Size
(Total Sales/Revenue)

Order at top of page
Total Firms
Total Employees
Average Revenue Per Firm
Average Employees Per Firm
Statistics Source: U.S. Census, AnythingResearch Market Analysis

Market Forecast

Market forecasts show the long term industry outlook and future growth trends. The following five-year demand forecast projects both short-term and long-term trends.

market forecast

Forecast / Industry Outlook 2017 2018 2019 2020 2021 2022
Market Forecast ($ millions)
Projected Industry Growth Rate (%)
Source: AnythingResearch Economic Analysis

Product & Services Breakdown

Research products and services in the Biological Product Manufacturing industry generating sales. Note that products are broken into categories with different levels of classification.

Product Description Sales ($ millions) Percent of Total Sales

Industry Total

Pharmaceutical Preparation Manufacturing

Biological Product (Except Diagnostic) Manufacturing

Other Biologics, Excluding Diagnostic, For Human Use

Total Miscellaneous Receipts

Resales - Sales Of Products Bought And Sold Without Further Manufacture, Processing, Or Assembly

Contract Work - Receipts For Work Done For Others On Their Materials

U.S. Geographic Distribution: Revenue Statistics by State

Market Size by State ($ millions) indicates how the industry's competition is distributed throughout the country. State-level information can identify areas with higher and lower industry market share than average.

U.S. map by state

Biological Product Manufacturing Industry Price Trends

Rise and fall in market prices are affectedd by supply, demand, and the cost of goods/services sold. Higher demand or COGS will put upward price pressure on prices. Higher competition among Biological Product Manufacturing companies will put a downward pressure on prices. The chart shows how prices are changing within the industry, month-to-month over the last three years.

example price index trendline

Income Statement (Average Financial Metrics)

Financial metrics provide a snapshot view of a benchmark "average" company. Key business metrics show revenue and operating costs. The data collected covers both public and private companies.

Industry AveragePercent of Sales
(Industry Benchmark)
Total Revenue

Order at top of page
Operating Revenue
Cost of Goods Sold
Gross Profit

Operating Expenses
Pension, profit sharing plans, stock, annuity
Rent paid on business property
Charitable Contributions
Domestic production activities deduction
Compensation of officers
Salaries and wages
Employee benefit programs
Taxes and Licenses
Bad Debts
Other Operating Expenses
Total Operating Expenses
Operating Income
Non-Operating Income
EBIT (Earnings Before Interest and Taxes)
Interest Expense
Earnings Before Taxes
Income Tax
Net Profit
Source: AnythingResearch Analysis of U.S. federal statistics

Financial Ratio Analysis

Financial ratio information can be used to benchmark how a Biological Product Manufacturing company compares to its peers. Accounting statistics are calculated from the industry-average for income statements and balance sheets.

Profitability & Valuation RatiosIndustry Average
Company valuation can be measured based on the firm's own performance, as well as in comparison against its industry competitors. These metrics show how the average company in the Biological Product Manufacturing industry is performing.
Profit Margin
Gross Profit Margin, Operating Profit Margin, and Net Profit Margin. Show company earnings relative to revenues.
Return on Equity (ROE)
Return on Equity (ROE) is net income as a percentage of shareholders' equity. Shareholders' Equity is defined as the company's total assets minus total liabilities. ROE shows how much profits a company generates with the money shareholders invested (or with retained earnings).
Return on Assets (ROA)
Return on Assets (ROA) is net income relative to total assets. The market research on Biological Product Manufacturing measures how efficiently the company leverages its assets to generate profit. ROA is calculated as Net Income divided by Total Assets.

Liquidity RatiosIndustry Average
Bankers and suppliers use liquidity to determine creditworthiness and identify potential threats to a company's financial viability.
Current Ratio
Measures a firm's ability to pay its debts over the next 12 months.
Quick Ratio (Acid Test)
Calculates liquid assets relative to liabilities, excluding inventories.

Efficiency Ratios - Key Performance IndicatorsIndustry Average
Measure how quickly products and services sell, and effectively collections policies are implemented.
Receivables Turnover Ratio
If this number is low in your business when compared to the industry average in the research report, it may mean your payment terms are too lenient or that you are not doing a good enough job on collections.
Average Collection Period
Based on the Receivables Turnover, this estimates the collection period in days. Calculated as 365 divided by the Receivables Turnover
Inventory Turnover
A low turnover rate may point to overstocking, obsolescence, or deficiencies in the product line or marketing effort.
Fixed-Asset Turnover
Generally, higher is better, since it indicates the business has less money tied up in fixed assets for each dollar of sales revenue.

Compensation & Salary Surveys for Employees

Compensation statistics provides an accurate assessment of industry-specific jobs and national salary averages. This information can be used to identify which positions are most common, and high, low, and average annual wages.

TitlePercent of WorkforceBottom Quartile Average (Median) SalaryUpper Quartile
Management Occupations 11%

Order at top of page
Chief Executives0%
General and Operations Managers2%
Business and Financial Operations Occupations 8%
Business Operations Specialists 7%
Architecture and Engineering Occupations 6%
Life, Physical, and Social Science Occupations 16%
Life Scientists 6%
Physical Scientists 6%
Chemists and Materials Scientists 5%
Chemists 5%
Office and Administrative Support Occupations 9%
Production Occupations 32%
Other Production Occupations 26%
Packaging and Filling Machine Operators and Tenders 8%
Packaging and Filling Machine Operators and Tenders 8%
Source: Bureau of Labor Statistics

Biological Product Manufacturing Industry Market Share [PREMIUM]

Largest companies in the industry and related industries, with private company revenue estimates.

CompanyAddressRevenue Estimate

Innovation News

  • Rpeptide patents Anti-amyloid-beta Antibodies - 02/22/2018
  • Takara Bio Usa patents Amplification And Analysis Of Whole Genome And Whole Transcriptome Libraries Generated By A Dna Polymerization Process - 02/01/2018
  • CRISPR Therapeutics AG patents Materials And Methods For Treatment Of Hemoglobinopathies - 02/01/2018
  • Longeveron trademarks "LMSC" - Stem cells for scientific and research purposes - 12/04/2017
  • Smart Surgical trademarks "MY BIOPORTAL" - Human allograft tissue; Stem cells for medical purposes - 11/15/2017
  • Longeveron raises $9 million in funding. - 11/06/2017
  • Crossing Cultures raises $1 million in funding. - 11/03/2017
  • Crossing Cultures trademarks "GODDESS GARDEN FRESH START" - Anti-aging cleanser; Facial cleansers; Fragranced face care preparations - 10/09/2017
  • CRISPR Therapeutics AG raises $35 million in funding. - 11/04/2016

  • Top Innovators

    CompanyInnovation Score
    Takara Bio Usa37
    CRISPR Therapeutics AG
    Accurate Chemical & Scientific

    Additional companies, details and innovation scoring in the full report.

    Latest Industry News

    • GenCure Opens BioManufacturing Center for Large-Scale Production of Adult Stem Cells to Support Development of New Cellular Therapies - Mike Fiske, GenCure vice president of cell manufacturing, noted, “The GenCure BioManufacturing Center is unique in that it not only provides a key bridge from discovery research to the evaluation of products in human clinical trials, but it is also ... (01/10/2018)
    • Global Biological Safety Testing Market to Grow at a CAGR of 11.12% During the Period 2017 – 2021; Finds New Report - Biological safety ensures the biological integrity of products that are meant for consumption ... efficient handling and compliance with regulatory procedures and good manufacturing practices. Due to the growing prevalence of chronic diseases, laboratories ... (01/09/2018)
    • The Crackdown Continues: FDA Takes Action Against Company And Its Autologous Stem Cell Product, Alleging Significant Safety Concerns - The agency determined that Atcell is not only an HCT/P subject to section 361 of the Public Health Service Act (42 USC 264), but also constitutes a biological product requiring ... Ensuring adequate control of over manufacturing processes clearly is ... (01/08/2018)
    • AGC Bioscience, Biomeva, and CMC Biologics to provide services under the brand AGC Biologics - ... is a leading global Contract Development and Manufacturing Organization (CDMO), with a strong commitment to deliver the highest standard of service to our clients and partners. AGC Biologics is the product of the convergence and integration of Asahi ... (01/08/2018)
    • Enable Injections Achieves ISO 13485:2016 Certification to Meet Mounting Demand for Drug-Delivery Device Combination Products - “As demand for our enFuse drug delivery platform accelerates, our pharma partners can be assured that Enable Injections is committed to designing and manufacturing the highest quality, most advanced and most patient-friendly biologics delivery technology ... (01/08/2018)
    • Biological Heart Valves Market Analysis by Material, Application, and Geography- Global Forecast to 2021 - The report firstly introduced the Biological Heart Valves basics: definitions, classifications, applications and market overview; product specifications; manufacturing processes; cost structures, raw materials and so on. Then it analyzed the world's main ... (01/06/2018)
    • FDA warns American CryoStem Corporation of significant deviations related to its unapproved stem cell product, Atcell - These manufacturing steps alter the original relevant characteristics ... and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security ... (01/06/2018)
    • Atlanta biological company bought by Minnesota firm - Minneapolis-based Bio-Techne Corp., which makes biological supplies and machines used in research ... “Atlanta Biologicals is a great fit with the Bio-Techne product portfolio as we continue to expand our cell culture and tissue regeneration capabilities ... (01/04/2018)
    • Samsung BioLogics named best bio product firm in Asia - Samsung BioLogics was named as the best biomedicine contract manufacturing company in Asia, the company said Wednesday. The biologics product manufacturing affiliate of Samsung Group said it won the recognition at the Asia-Pacific Bioprocessing Excellence ... (02/15/2017)

    Government Contracts

    In 2016, the federal government spent a total of $563,843,290 on Biological Product Manufacturing. It has awarded 1,583 contracts to 281 companies, with an average value of $2,006,560 per company.   

    Top government vendors:

    CompanyFederal ContractsTotal Award Amount

    Segments classified within this market research report

    This industry market research report includes companies whose primary business is any of the following:
    Bacterial vaccines manufacturing, Vaccines (i.e., bacterial, virus) manufacturing, Tuberculin (i.e., tuberculo-protein derived) manufacturing, Virus vaccines manufacturing, Antiserums manufacturing, Bacterins (i.e., bacterial vaccines) manufacturing, Serums (except diagnostic substances) manufacturing, Antigens manufacturing, Blood fractions manufacturing, Antivenoms manufacturing, Plasmas manufacturing, Agar culture media manufacturing, Antitoxins manufacturing, Blood derivatives manufacturing, Culture media manufacturing, Toxoids (e.g., diphtheria, tetanus) manufacturing, Allergens manufacturing, Gene therapy preparations manufacturing, Aggressins (except in-vitro) manufacturing, Allergenic extracts (except diagnostic substances) manufacturing, Cholera serums manufacturing, Hematology products (except diagnostic substances) manufacturing, etc.

    Related Reports

    Can't find what you're looking for? We have over a thousand market research reports. Ask us and an analyst will help you find what you need.

    Industries Related to Biological Product Manufacturing

    Biological Product Manufacturing